Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-24

Clinical Trial Update: Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial sponsored by Roswell Park Cancer Institute is evaluating the delivery of tetrahydrocannabinol (THC) vaping liquids and their eff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tetrahydrocannabinol (THC) (tetrahydrocannabinol)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Cannabis Dependence | EARLY_Phase 1 | Status: NOT_YET_RECRUITING